Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
The New Standard for Proper and Safe Repairs
Quick—which has the most complicated computer systems: a space shuttle, a fighter plane or a 2019 SUV?
Top Six Benefits IoT Offers the Automotive Claims Industry
Just one poor claims experience will lead more than 30 percent of customers to switch carriers within a year of the incident.1 How can i
3 Takeaways from WCRI
WCRI’s recent annual conference delivered valuable research and insight on the current (and future) state of the industry.
Quarterly Drug Update: Evaluating Combination Medications
Learn what combination medications are, how they impact workers' compensation claims and what major combination medications your program should ev
WorkCompWire: Shore Up the Home Health Staffing Shortage with a Deep Bench of Expertise
When employees sustain complex, severe or catastrophic injuries, they may require home health services.
WorkCompWire: How Outdated Imaging Equipment is Impacting Quality of Care and Claim Costs
In workers’ compensation, diagnostic imaging – such as an MRI, CT, or PET scan – is often the first critical step to assess the severity of a